Putting Alzheimer’s on early notice

July 16, 2010
Putting Alzheimer’s on early notice
In vivo imaging of amyloid-beta plaques and brain atrophy of a healthy elderly person (left) compared to an Alzheimer's disease patient (right). (CSIRO)

Australian scientists have presented key findings at an international Alzheimer's disease conference this week. Their major focus is on early detection and discovering why the disease progresses.

The International Conference on in Hawaii heard that scientists from the Australian Imaging Biomarkers and Lifestyle Flagship Study of Ageing (AIBL) have identified advances in imaging and blood screening that will contribute to the earlier detection of Alzheimer’s.

About 250,000 Australians currently have Alzheimer’s disease, but numbers are anticipated to rise to 1.3 million in the next 40 years if there were not significant breakthroughs in prevention and treatment of the disease.

The national collaborative approach taken by AIBL scientists was initiated by CSIRO’s Preventative Health National Research Flagship on Alzheimer’s prevention research and has resulted in 22 research papers being accepted and presented at the conference.

The director of CSIRO’s Preventative Health Flagship, Professor Richard Head, said many of the major contributions presented at the conference were only made possible through the national collaboration of scientists from a wide range of disciplines across Australia.

"This collaboration has provided critical expertise and capability at a size necessary to enable us to understand early identification of the disease and the contributing factors to its progression," Professor Head said. 

"The advancement in our research would not have been as strong or as rapid were it not for the broad range of expertise brought together by this collaboration."

The level of recognition from the world’s leading forum on research confirms the success of the initiative, he said.

Professor Head said the AIBL research has combined advanced neuroimaging, cognitive performance studies, blood screening and lifestyle studies to start identifying early indicators of the disease.

"The imaging component alone has potentially brought forward the detection of Alzheimer's disease by 18 months," he said.

Related Stories

Recommended for you

Fatty liver: Turning off TAZ reverses disease

October 27, 2016

Scientists at Columbia University Medical Center (CUMC) have identified a factor in liver cells that is responsible for turning a relatively benign liver condition, present in 30 percent of U.S. adults, into a serious disease ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.